LINC00892

Across TCGA pan-cancer cohorts, LINC00892 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of LINC00892’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC00892 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00892 is over-expressed in tumor, although a few such as COAD and LUSC show the opposite, repressed pattern.

COAD, LUSC, and KIRC are the cancer types where LINC00892 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00892 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	−0.500	<.001	9	view →
LUSC	Male	II,III,IV	−1.238	<.001	8	view →
KIRC	Male	IV	+0.591	<.001	8	view →
HNSC	Male	II,III,IV	−0.258	<.001	8	view →
LUAD	Female	II,III,IV	−1.061	<.001	7	view →
BLCA	Female	All	−0.639	.001	6	view →
THCA	All	All	−0.312	.006	6	view →
UCEC	All	All	−0.256	<.001	6	view →
KICH	All	All	−0.268	.001	4	view →
LIHC	Female	All	+0.147	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

LINC00892–COAD

Open the COAD breakdown →